MA45580A - Titrage basal avec glycémie cible adaptative - Google Patents

Titrage basal avec glycémie cible adaptative

Info

Publication number
MA45580A
MA45580A MA045580A MA45580A MA45580A MA 45580 A MA45580 A MA 45580A MA 045580 A MA045580 A MA 045580A MA 45580 A MA45580 A MA 45580A MA 45580 A MA45580 A MA 45580A
Authority
MA
Morocco
Prior art keywords
adaptive target
basal titration
target glycemia
glycemia
titration
Prior art date
Application number
MA045580A
Other languages
English (en)
Inventor
Tinna Björk Aradóttir
Henrik Bengtsson
Pete Brockmeier
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA45580A publication Critical patent/MA45580A/fr

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2093—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically including concentration setting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3306—Optical measuring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6054—Magnetic identification systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/005—Parameter used as control input for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/50—Temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Psychiatry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MA045580A 2016-07-08 2017-06-23 Titrage basal avec glycémie cible adaptative MA45580A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16178554 2016-07-08

Publications (1)

Publication Number Publication Date
MA45580A true MA45580A (fr) 2019-05-15

Family

ID=56464025

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045580A MA45580A (fr) 2016-07-08 2017-06-23 Titrage basal avec glycémie cible adaptative

Country Status (6)

Country Link
US (1) US11373746B2 (fr)
EP (1) EP3481274B1 (fr)
JP (1) JP6756030B2 (fr)
CN (1) CN109661196B (fr)
MA (1) MA45580A (fr)
WO (1) WO2018007172A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10852069B2 (en) 2010-05-04 2020-12-01 Fractal Heatsink Technologies, LLC System and method for maintaining efficiency of a fractal heat sink
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2020002428A1 (fr) * 2018-06-26 2020-01-02 Novo Nordisk A/S Système fournissant des recommandations de dose pour le titrage de l'insuline basale
US11967407B2 (en) * 2018-07-26 2024-04-23 Sanofi Method of adjusting medication doses
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
WO2021034784A1 (fr) 2019-08-16 2021-02-25 Poltorak Technologies, LLC Dispositif et procédé de diagnostic médical
US11801344B2 (en) * 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
EP4042435A1 (fr) * 2019-10-11 2022-08-17 Bigfoot Biomedical, Inc. Ajustement du réglage d'une thérapie à l'insuline sur la base de la variabilité des valeurs de glycémie
US20230005587A1 (en) * 2019-12-03 2023-01-05 Bigfoot Biomedical, Inc. Determining whether adjustments of insulin therapy recommendations are being taken into account
WO2022234032A2 (fr) * 2021-05-05 2022-11-10 Novo Nordisk A/S Méthodes et systèmes d'estimation de valeurs de glucose à jeun
US20230061867A1 (en) * 2021-08-26 2023-03-02 Nxp B.V. System, Device and Method for Multi-Device Authentication
CN114081484B (zh) * 2021-11-24 2024-02-27 上海微创生命科技有限公司 连续血糖检测方法、系统及可读存储介质
CN118661227A (zh) 2022-01-31 2024-09-17 诺和诺德股份有限公司 用于个性化胰岛素滴定的系统和方法
US12576208B2 (en) 2022-04-26 2026-03-17 Dexcom, Inc. System and method for titrating basal insulin doses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11296598A (ja) 1998-04-07 1999-10-29 Seizaburo Arita 血糖値の予測システム及び予測方法並びにこの方法を記録した記録媒体
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6883521B2 (en) 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2005113036A1 (fr) 2004-05-13 2005-12-01 The Regents Of The University Of California Procede et dispositif de regulation du glucose et de dosage de l'insuline pour des sujets diabetiques
US7291107B2 (en) 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
GB2436873A (en) 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
WO2009001349A1 (fr) 2007-06-25 2008-12-31 Medingo Ltd. Système d'administration d'insuline basale personnalisé
CA2720304C (fr) 2008-04-04 2018-05-15 Hygieia, Inc. Appareil pour optimiser un regime posologique d'insuline d'un patient
EP2277123B1 (fr) 2008-04-29 2019-08-07 Roche Diabetes Care GmbH Procédé de sélection de doses de bolus et de motifs d'administration de bolus dans un dispositif d'administration de médicament
WO2009146445A1 (fr) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Procédé et système fournissant un contrôle glycémique
US8527208B2 (en) * 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
BRPI1008842B1 (pt) 2009-02-04 2021-04-13 Sanofi-Aventis Deutschland Gmbh Dispositivo e método médicos para proporcionarem um controle glicêmico com base em informações de resposta glicêmica
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
US8532933B2 (en) * 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
ES2755497T3 (es) 2010-10-31 2020-04-22 Univ Boston Sistema de control de glucosa en sangre
US9636461B2 (en) 2011-05-06 2017-05-02 Novo Nordisk A/S System for optimizing a drug dosage regimen over time
EP2748747B1 (fr) 2011-08-26 2020-08-26 University Of Virginia Patent Foundation Procédé, système et support lisible par ordinateur pour la régulation adaptative conseillée du diabète
US10391242B2 (en) 2012-06-07 2019-08-27 Medtronic Minimed, Inc. Diabetes therapy management system for recommending bolus calculator adjustments
KR101981836B1 (ko) 2012-08-24 2019-05-23 에프. 호프만-라 로슈 아게 정정 식사 상승 값을 결정하는 방법
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
CA2895538A1 (fr) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. Systeme et procede pour prendre en charge le diabete sur la base de la mediane du glucose, de la variabilite du glucose, et du risque hypoglycemique
JP2016530905A (ja) 2013-06-21 2016-10-06 フレゼニウス ヴィアル エスアーエスＦｒｅｓｅｎｉｕｓ Ｖｉａｌ ＳＡＳ 患者へのインスリンの投与を制御する方法及び制御デバイス
WO2015021041A2 (fr) 2013-08-05 2015-02-12 Hygieia, Inc. Systèmes, dispositifs et procédés pour atténuer la glucotoxicité et restaurer la fonction des cellules bêta pancréatiques en cas de diabète sucré avancé
AU2015100005A4 (en) 2014-01-27 2015-02-12 Digital Medics Pty. Ltd. Diabetic Connect Bluetooth Adaptor

Also Published As

Publication number Publication date
CN109661196A (zh) 2019-04-19
EP3481274A1 (fr) 2019-05-15
US20190147999A1 (en) 2019-05-16
EP3481274B1 (fr) 2023-01-25
JP2019531522A (ja) 2019-10-31
WO2018007172A1 (fr) 2018-01-11
JP6756030B2 (ja) 2020-09-16
CN109661196B (zh) 2022-03-29
US11373746B2 (en) 2022-06-28

Similar Documents

Publication Publication Date Title
MA45580A (fr) Titrage basal avec glycémie cible adaptative
EP3504327A4 (fr) Nucléases spécifiques de cible spécifiquement modifiées
EP3710547A4 (fr) Revêtements thermoscellables
EP3718819A4 (fr) Mécanisme de retournement
EP3423186A4 (fr) Revêtement de micro-extraction en phase solide
EP3436607A4 (fr) Capture de cible duplex liée
EP3373952A4 (fr) Leurres nkg2d
EP3733844A4 (fr) Composition de modification de gène cible
EP3433563A4 (fr) Étui de pistolet
BR112017022231A2 (pt) atuadores de onda
MA49422A (fr) Titrage basal avec glycémie cible adaptative
EP3710548A4 (fr) Revêtements thermoscellables
EP3423626A4 (fr) Revêtement électroconducteur
EP3677506A4 (fr) Corps volant
EP3838358A4 (fr) Lanceur multidirectionnel
EP3458777C0 (fr) Four
DK3625104T3 (da) Ukrudtsbekæmpelse ved høj hastighed
EP3545238A4 (fr) Four
EP3521179A4 (fr) Mécanisme de pointage
EP3658825A4 (fr) Four
EP3685103A4 (fr) Four
EP3731387A4 (fr) Actionneur
EP3679100A4 (fr) Revêtements glaciophobes thermiquement conducteurs
EP3375545A4 (fr) Buse immergée
EP3556900A4 (fr) Élément résistant à la corrosion